PEVC case study: Biotech investment with a complex capital structure

3 months ago · 25 min watch

SECTION

EXCLUSIVE

In this real-world case study, three investors examine the valuation of a clinical-stage biotech company using three different methods. However, they arrive at similar conclusions.

Reserved for FVS Section members and PEVC Content Subscriptions

Already an FVS Section member or PEVC Content Subscription?

Log in with your AICPA account

Not an FVS Section member or PEVC Content Subscription?

Discover the benefits of AICPA membership, Forensic & Valuation Services Section membership, Private Equity and Venture Capital Topic Subscription. To gain access to exclusive content, your first step is to join the AICPA.

Learn more about Forensic & Valuation Services Section membership

Learn more about Private Equity and Venture Capital Topic Subscription